This inventor holds 6 USPTO granted patents and 2 published patent applications, plus 4 CIPO patents and 3 EPO patents. Top assignees: National Taiwan University, National Yang Ming Chiao Tung University, National Health Research Institutes. Active years: 2013-2025.
Location History:
- Taipei, TW (2013)
- Stafford, VA (US) (2018 - 2022)
Company Filing History:


Years Active: 2013-2025
Title: Yufeng Jane Tseng: Innovator in Neurological Disorder Treatments
Introduction
Yufeng Jane Tseng is a notable inventor based in Stafford, VA (US). He has made significant contributions to the field of medicinal chemistry, particularly in the development of compounds aimed at treating neurological disorders. With a total of 6 patents to his name, Tseng's work is recognized for its potential impact on healthcare.
Latest Patents
Among his latest innovations are the novel substituted benzimidazole derivatives, which serve as D-amino acid oxidase (DAAO) inhibitors. These compounds are designed for the treatment and/or prevention of neurological disorders. The significance of this invention lies in its potential to provide new therapeutic options for patients suffering from various neurological conditions.
Career Highlights
Throughout his career, Yufeng Jane Tseng has been associated with prestigious institutions such as National Taiwan University and National Yang Ming Chiao Tung University. His work in these academic environments has allowed him to collaborate with other experts in the field and contribute to groundbreaking research.
Collaborations
Some of his notable coworkers include Chung-Ming Sun and Yu-Li Liu, who have also made significant contributions to the field of medicinal chemistry. Their collaborative efforts have further advanced the research and development of innovative treatments.
Conclusion
Yufeng Jane Tseng's contributions to the field of medicinal chemistry, particularly through his patented inventions, highlight his role as a key innovator in the treatment of neurological disorders. His work continues to inspire advancements in healthcare and therapeutic development.